Our dedicated Urology and Head and Neck Trials team, led by Professor Emma Hall, carries out clinical trials for the treatment of head and neck cancers, as well as prostate cancer, testicular cancer and bladder cancer.
Take a look at all clinical trials currently being run for head and neck cancer.
Blood test predictors
Human papillomavirus (HPV) is a known driver of head and neck cancer in some patients. Our scientists at the ICR and The Royal Marsden developed a blood test that can detect whether patients with HPV-positive head and neck cancer will have residual tumours, even after chemotherapy and radiotherapy.
The test also identified patients who are more likely to respond better to treatment. This could reduce the number of HPV-positive patients who undergo unnecessary surgery, while making it easier to detect those who have relapsed.
The Oracle Cancer Trust
We work with the Oracle Cancer Trust, a charity which provides grants to fund pioneering research projects into head and neck cancer, and supports our PhD students and post-doctoral researchers to discover smarter, kinder treatments for patients.
The trust has funded vital research by Professor Kevin Harrington and Dr Martin McLaughlin on accelerating cell death in head and neck cancer using a viral therapy.
Support our research